JP2010538643A - 遺伝マーカー及び関連するエピスタシス交互作用の使用方法 - Google Patents
遺伝マーカー及び関連するエピスタシス交互作用の使用方法 Download PDFInfo
- Publication number
- JP2010538643A JP2010538643A JP2010524845A JP2010524845A JP2010538643A JP 2010538643 A JP2010538643 A JP 2010538643A JP 2010524845 A JP2010524845 A JP 2010524845A JP 2010524845 A JP2010524845 A JP 2010524845A JP 2010538643 A JP2010538643 A JP 2010538643A
- Authority
- JP
- Japan
- Prior art keywords
- animal
- genotype
- snps
- loci
- listed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000003993 interaction Effects 0.000 title claims abstract description 52
- 230000002068 genetic effect Effects 0.000 title description 61
- 241001465754 Metazoa Species 0.000 claims abstract description 169
- 238000000034 method Methods 0.000 claims abstract description 105
- 230000001488 breeding effect Effects 0.000 claims abstract description 82
- 238000009395 breeding Methods 0.000 claims abstract description 79
- 230000000694 effects Effects 0.000 claims abstract description 67
- 108090000623 proteins and genes Proteins 0.000 claims description 74
- 108700028369 Alleles Proteins 0.000 claims description 71
- 239000003550 marker Substances 0.000 claims description 60
- 238000004458 analytical method Methods 0.000 claims description 47
- 235000013336 milk Nutrition 0.000 claims description 38
- 239000008267 milk Substances 0.000 claims description 38
- 210000004080 milk Anatomy 0.000 claims description 38
- 238000004519 manufacturing process Methods 0.000 claims description 26
- 102000054765 polymorphisms of proteins Human genes 0.000 claims description 22
- 230000035935 pregnancy Effects 0.000 claims description 18
- 210000001082 somatic cell Anatomy 0.000 claims description 18
- 239000002773 nucleotide Substances 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 17
- 230000013011 mating Effects 0.000 claims description 14
- 230000006651 lactation Effects 0.000 claims description 12
- 102000014171 Milk Proteins Human genes 0.000 claims description 10
- 108010011756 Milk Proteins Proteins 0.000 claims description 10
- 235000021243 milk fat Nutrition 0.000 claims description 10
- 235000021239 milk protein Nutrition 0.000 claims description 10
- 230000009027 insemination Effects 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 210000001161 mammalian embryo Anatomy 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 7
- 230000004720 fertilization Effects 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 150000007523 nucleic acids Chemical group 0.000 claims description 5
- 235000013601 eggs Nutrition 0.000 claims description 4
- 230000002688 persistence Effects 0.000 claims description 4
- 238000003499 nucleic acid array Methods 0.000 claims 4
- 235000013365 dairy product Nutrition 0.000 abstract description 18
- 238000012360 testing method Methods 0.000 abstract description 16
- 238000010348 incorporation Methods 0.000 abstract 1
- 244000309464 bull Species 0.000 description 105
- 241000283690 Bos taurus Species 0.000 description 56
- 102000054766 genetic haplotypes Human genes 0.000 description 33
- 238000009396 hybridization Methods 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 16
- 244000309466 calf Species 0.000 description 15
- 210000000349 chromosome Anatomy 0.000 description 13
- 238000013507 mapping Methods 0.000 description 13
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 238000001514 detection method Methods 0.000 description 11
- 230000035772 mutation Effects 0.000 description 11
- 101100478277 Homo sapiens SPTA1 gene Proteins 0.000 description 10
- 102100037608 Spectrin alpha chain, erythrocytic 1 Human genes 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 7
- 244000144980 herd Species 0.000 description 7
- 238000011002 quantification Methods 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 6
- 230000001364 causal effect Effects 0.000 description 6
- 230000007614 genetic variation Effects 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 208000002254 stillbirth Diseases 0.000 description 6
- 231100000537 stillbirth Toxicity 0.000 description 6
- 108091035707 Consensus sequence Proteins 0.000 description 5
- 230000002759 chromosomal effect Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000003234 polygenic effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 102100028004 Cation channel sperm-associated protein 1 Human genes 0.000 description 4
- 102100037182 Cation-independent mannose-6-phosphate receptor Human genes 0.000 description 4
- 101000859052 Homo sapiens Cation channel sperm-associated protein 1 Proteins 0.000 description 4
- 101001028831 Homo sapiens Cation-independent mannose-6-phosphate receptor Proteins 0.000 description 4
- 101001074548 Homo sapiens Regulating synaptic membrane exocytosis protein 2 Proteins 0.000 description 4
- 101001078082 Homo sapiens Reticulocalbin-3 Proteins 0.000 description 4
- 101000801209 Homo sapiens Transducin-like enhancer protein 4 Proteins 0.000 description 4
- 102100032352 Leukemia inhibitory factor Human genes 0.000 description 4
- 108090000581 Leukemia inhibitory factor Proteins 0.000 description 4
- 108090000630 Oncostatin M Proteins 0.000 description 4
- 102100031942 Oncostatin-M Human genes 0.000 description 4
- 102100036266 Regulating synaptic membrane exocytosis protein 2 Human genes 0.000 description 4
- 102100025343 Reticulocalbin-3 Human genes 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 238000000018 DNA microarray Methods 0.000 description 3
- 102100033763 Transducin-like enhancer protein 4 Human genes 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 239000012805 animal sample Substances 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 238000012098 association analyses Methods 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000003205 genotyping method Methods 0.000 description 3
- 238000009399 inbreeding Methods 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 230000008774 maternal effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000008775 paternal effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102100022595 Broad substrate specificity ATP-binding cassette transporter ABCG2 Human genes 0.000 description 2
- 102100036727 Deformed epidermal autoregulatory factor 1 homolog Human genes 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102100020948 Growth hormone receptor Human genes 0.000 description 2
- 101000929421 Homo sapiens Deformed epidermal autoregulatory factor 1 homolog Proteins 0.000 description 2
- 101000690100 Homo sapiens U1 small nuclear ribonucleoprotein 70 kDa Proteins 0.000 description 2
- 102100040557 Osteopontin Human genes 0.000 description 2
- 101100029173 Phaeosphaeria nodorum (strain SN15 / ATCC MYA-4574 / FGSC 10173) SNP2 gene Proteins 0.000 description 2
- 101100094821 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SMX2 gene Proteins 0.000 description 2
- 206010042573 Superovulation Diseases 0.000 description 2
- 102100024121 U1 small nuclear ribonucleoprotein 70 kDa Human genes 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000012173 estrus Effects 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 230000004983 pleiotropic effect Effects 0.000 description 2
- -1 poulF1 Proteins 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 238000013179 statistical model Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 description 1
- 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 description 1
- 102100036869 Diacylglycerol O-acyltransferase 1 Human genes 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 238000001134 F-test Methods 0.000 description 1
- 101000823298 Homo sapiens Broad substrate specificity ATP-binding cassette transporter ABCG2 Proteins 0.000 description 1
- 101000927974 Homo sapiens Diacylglycerol O-acyltransferase 1 Proteins 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 238000003657 Likelihood-ratio test Methods 0.000 description 1
- 108010090306 Member 2 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010081689 Osteopontin Proteins 0.000 description 1
- 102100039824 Pre T-cell antigen receptor alpha Human genes 0.000 description 1
- 108010068542 Somatotropin Receptors Proteins 0.000 description 1
- 101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 description 1
- 241000188156 Tamu Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 1
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 description 1
- 101150064029 bi gene Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000019788 craving Nutrition 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000640 hair analysis Toxicity 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 238000001558 permutation test Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000005476 size effect Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000021246 κ-casein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97175007P | 2007-09-12 | 2007-09-12 | |
| PCT/US2008/010480 WO2009035560A1 (en) | 2007-09-12 | 2008-09-08 | Methods of using genetic markers and related epistatic interactions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010538643A true JP2010538643A (ja) | 2010-12-16 |
| JP2010538643A5 JP2010538643A5 (enExample) | 2011-09-15 |
Family
ID=40452316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010524845A Abandoned JP2010538643A (ja) | 2007-09-12 | 2008-09-08 | 遺伝マーカー及び関連するエピスタシス交互作用の使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110123983A1 (enExample) |
| EP (1) | EP2201133A4 (enExample) |
| JP (1) | JP2010538643A (enExample) |
| CN (1) | CN101970688A (enExample) |
| AU (1) | AU2008300011A1 (enExample) |
| BR (1) | BRPI0816776A2 (enExample) |
| CA (1) | CA2698379A1 (enExample) |
| MX (1) | MX2010002759A (enExample) |
| WO (1) | WO2009035560A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016521984A (ja) * | 2013-06-14 | 2016-07-28 | キージーン ナムローゼ フェンノートシャップ | 表現形質改善のための制御された戦略 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10102333B2 (en) * | 2013-01-21 | 2018-10-16 | International Business Machines Corporation | Feature selection for efficient epistasis modeling for phenotype prediction |
| CN103155903B (zh) * | 2013-03-18 | 2014-09-03 | 中国农业科学院兰州畜牧与兽药研究所 | 一种欧拉羊复壮的方法 |
| US20150181822A1 (en) | 2013-12-31 | 2015-07-02 | Dow Agrosciences Llc | Selection based on optimal haploid value to create elite lines |
| CN103914632A (zh) * | 2014-02-26 | 2014-07-09 | 中国农业大学 | 一种快速估计基因组育种值的方法和应用 |
| EP3328192A1 (en) * | 2015-07-29 | 2018-06-06 | Genus Plc | Method of breeding cows for improved milk yield |
| CN109101786B (zh) * | 2018-08-29 | 2021-02-09 | 广东省农业科学院动物科学研究所 | 一种整合显性效应的基因组育种值估计方法 |
| CN109321639A (zh) * | 2018-10-10 | 2019-02-12 | 北京奶牛中心 | 基于KASP技术检测κ-酪蛋白基因型的方法 |
| CN109744195B (zh) * | 2018-12-28 | 2020-12-15 | 广州影子科技有限公司 | 一种动物育种中利用亲代基因组信息的精准选配方法 |
| CN113345520B (zh) * | 2021-06-07 | 2021-12-14 | 北京林业大学 | 一种基于Richards方程的树木数量性状的QTL定位框架的方法 |
| CN116863998B (zh) * | 2023-06-21 | 2024-04-05 | 扬州大学 | 一种基于遗传算法的全基因组预测方法及其应用 |
| CN117757959B (zh) * | 2024-02-22 | 2024-06-14 | 海南省农业科学院三亚研究院(海南省实验动物研究中心) | 一种与母猪难产性状相关的snp分子标记及应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5041371A (en) * | 1989-03-15 | 1991-08-20 | Wisconsin Alumni Research Foundation | Genetic marker for superior milk products in dairy cattle |
| AU3919693A (en) * | 1992-03-17 | 1993-10-21 | Board of Trustees of The University of Illinois at Urbana-Champaign, The | Bovine alleles and genetic markers and methods of testing of and using same |
| US5374523A (en) * | 1992-08-10 | 1994-12-20 | Monsanto Company | Allelic variants of bovine somatotropin gene:genetic marker for superior milk production in bovine |
| US5614364A (en) * | 1994-05-16 | 1997-03-25 | Iowa State University Research Foundation, Inc. | Genetic marker for improved milk production traits in cattle |
| WO1999054735A1 (en) * | 1998-04-17 | 1999-10-28 | Innogenetics N.V. | Improved immunodiagnostic assays using reducing agents |
| US20020137139A1 (en) * | 1999-01-12 | 2002-09-26 | Byatt John C | Nucleic acid and other molecules associated with lactation and muscle and fat deposition |
| US6900016B1 (en) * | 2000-09-08 | 2005-05-31 | Applera Corporation | Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof |
| DE60126307T2 (de) * | 2000-10-31 | 2007-12-27 | Michel Alphonse Julien Georges | Marker-unterstützte auswahl von rindvieh für verbesserte milchproduktion unter verwendung des diacylglycerin-acyltransferase-gens dgat1 |
| CA2453001C (en) * | 2001-07-06 | 2011-05-24 | Arbeitsgemeinschaft Deutscher Rinderzuchter E.V. | Method of testing a mammal for its predisposition for fat content of milk and/or its predisposition for meat marbling |
| NZ591747A (en) * | 2001-07-16 | 2013-05-31 | Therapeutic Foods Ltd | Populations of dairy cows producing milk with desirable characteristics and methods of making and using same |
| US20030162207A1 (en) * | 2001-12-14 | 2003-08-28 | Comings David E. | Multi-gene tests with ROC plots for the assessment of risk for polygenic disorders |
| US20050136440A1 (en) * | 2002-03-11 | 2005-06-23 | Robert Renaville | Method for identifying animals for milk production qualities by analysing the polymorphism of the Pit-1 and kappa-casein genes |
| US20040241723A1 (en) * | 2002-03-18 | 2004-12-02 | Marquess Foley Leigh Shaw | Systems and methods for improving protein and milk production of dairy herds |
| ATE386823T1 (de) * | 2002-06-05 | 2008-03-15 | Sarah Blott | Marker-unterstützte rinderauswahl für verbesserte milchzusammensetzung |
| JP2005531325A (ja) * | 2002-07-03 | 2005-10-20 | エイツー・コーポレーション・リミテッド | 生乳の脂肪酸の組成を変える方法 |
| DE10238433A1 (de) * | 2002-08-16 | 2004-03-04 | Justus-Liebig-Universität Giessen | Verfahren zur Bestimmung des allelischen Zustandes des 5'-Ende des alpha-S1-Kaseingenes |
| US20040115701A1 (en) * | 2002-08-30 | 2004-06-17 | Comings David E | Method for risk assessment for polygenic disorders |
| DE10259714A1 (de) * | 2002-12-19 | 2004-07-08 | Biopsytec Analytik Gmbh | Verfahren zur Analyse des "Hornlos"(Polled)-Genotyps eines Nutztiers mittels genetischer Marker |
| CA2512134A1 (en) * | 2002-12-31 | 2004-07-22 | Mmi Genomics, Inc. | Compositions, methods and systems for inferring bovine traits |
| DK1437418T3 (da) * | 2003-01-10 | 2009-12-21 | Univ Liege | Udvælgelse af dyr for önskelige genotype eller potentielt phenotype egenskaber baseret på en enkelt nuklotidpolymorfisme (SNP) i intron 3 af IGF2-genet |
| NZ544952A (en) * | 2003-05-30 | 2009-12-24 | Univ Illinois | Gene expression profiles that identify genetically elite ungulate mammals |
| US8039686B2 (en) * | 2003-07-07 | 2011-10-18 | Pioneer Hi-Bred International, Inc. | QTL “mapping as-you-go” |
| WO2005040400A2 (en) * | 2003-10-24 | 2005-05-06 | Mmi Genomics, Inc. | Methods and systems for inferring traits to manage non-beef livestock |
| US7972783B2 (en) * | 2003-11-24 | 2011-07-05 | Branhaven LLC | Method and markers for determining the genotype of horned/polled cattle |
| AR046713A1 (es) * | 2003-11-24 | 2005-12-21 | Metamorphix Inc | Metodo y marcadores para determinar el genotipo de ganado con/sin cuerno |
| US20050123929A1 (en) * | 2003-12-04 | 2005-06-09 | Wisconsin Alumni Research Foundation | Methods and compositions for genetically detecting improved milk production traits in cattle |
| AU2005300688B2 (en) * | 2004-11-03 | 2012-02-02 | Almac Diagnostics Limited | Transcriptome microarray technology and methods of using the same |
| US20060166244A1 (en) * | 2005-01-14 | 2006-07-27 | The University Of Missouri System | DNA markers for increased milk production in cattle |
| US7897749B2 (en) * | 2005-07-13 | 2011-03-01 | Wisconsin Alumni Research Foundation | Dairy cattle breeding for improved milk production traits in cattle |
| US20070026493A1 (en) * | 2005-07-27 | 2007-02-01 | Can Technologies, Inc. | System and method for optimizing animal production using genotype information |
-
2008
- 2008-09-08 BR BRPI0816776A patent/BRPI0816776A2/pt not_active IP Right Cessation
- 2008-09-08 WO PCT/US2008/010480 patent/WO2009035560A1/en not_active Ceased
- 2008-09-08 US US12/674,164 patent/US20110123983A1/en not_active Abandoned
- 2008-09-08 EP EP08830289A patent/EP2201133A4/en not_active Withdrawn
- 2008-09-08 JP JP2010524845A patent/JP2010538643A/ja not_active Abandoned
- 2008-09-08 MX MX2010002759A patent/MX2010002759A/es not_active Application Discontinuation
- 2008-09-08 AU AU2008300011A patent/AU2008300011A1/en not_active Abandoned
- 2008-09-08 CN CN2008801157027A patent/CN101970688A/zh active Pending
- 2008-09-08 CA CA2698379A patent/CA2698379A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016521984A (ja) * | 2013-06-14 | 2016-07-28 | キージーン ナムローゼ フェンノートシャップ | 表現形質改善のための制御された戦略 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2201133A4 (en) | 2010-11-03 |
| WO2009035560A1 (en) | 2009-03-19 |
| AU2008300011A1 (en) | 2009-03-19 |
| EP2201133A1 (en) | 2010-06-30 |
| US20110123983A1 (en) | 2011-05-26 |
| CN101970688A (zh) | 2011-02-09 |
| BRPI0816776A2 (pt) | 2019-09-24 |
| CA2698379A1 (en) | 2009-03-19 |
| MX2010002759A (es) | 2010-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010538643A (ja) | 遺伝マーカー及び関連するエピスタシス交互作用の使用方法 | |
| CA2673174C (en) | Artificial selection method and reagents | |
| US20100162423A1 (en) | Methods and Systems for Inferring Traits to Breed and Manage Non-Beef Livestock | |
| JP2011505872A (ja) | 乳用動物および乳用生産物の遺伝的プロフィールを改良する方法 | |
| JP2011501659A (ja) | 有角および無角ウシの遺伝子マーカーおよび関連する方法 | |
| JP2020074781A (ja) | 乳生産量を改善するための雌牛の育種方法 | |
| US20070105107A1 (en) | Marker assisted best linear unbiased prediction (ma-blup): software adaptions for large breeding populations in farm animal species | |
| US20110054246A1 (en) | Whole genome scan to discover quantitative trai loci (qtl) affecting growth, body composition, and reproduction in maternal pig lines | |
| WO2008140467A2 (en) | Genetic markers and methods for improving dairy productivity and fitness traits | |
| JP2010533491A (ja) | 乳生産動物および乳業産物のゲノムマーカー指数を改善する方法 | |
| WO2009055805A2 (en) | Genetic markers and methods for improving swine genetics | |
| CN119177294B (zh) | 一种与猪乳头数性状相关的snp分子标记及其应用 | |
| RU2754039C2 (ru) | Способ прогнозирования резистентности | |
| WO2008024227A2 (en) | Genetic markers and methods for improving swine genetics | |
| Pienaar | Genetic diversity in the Afrikaner cattle breed | |
| STANOJEVIĆ et al. | Genomics as a Tool for Improving Dairy Cattle Populations | |
| US20190226028A1 (en) | Compositions and Methods for Determining Likelihood of an Increased Susceptibility to Contracting Johne's Disease | |
| CN120624662A (zh) | 与白羽肉种鸡蛋重性状相关的snp标记及其应用 | |
| Soattin | The use of molecular markers for analyzing genes and genomes of livestock |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110801 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110801 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20120412 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120508 |